Filing Details
- Accession Number:
- 0001209191-21-071311
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-27 19:34:40
- Reporting Period:
- 2021-12-27
- Accepted Time:
- 2021-12-27 19:34:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850261 | Sorrento Therapeutics Inc. | SRNE | Biological Products, (No Disgnostic Substances) (2836) | 330344842 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1518466 | Kim Janda | C/O Sorrento Therapeutics, Inc. 4955 Directors Place San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-27 | 3,000 | $4.00 | 6,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-27 | 3,000 | $5.88 | 3,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified stock option | Disposition | 2021-12-27 | 3,000 | $0.00 | 3,000 | $4.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-01-01 | 2022-02-06 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.